InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 EMD: EMD to Conduct Opioid Sparing Clinical Trial for Zelira 27 Feb 2020 9:30AM $0.048 $0.500 risen by 941.67%
$7 Phase 1 Opioid Reduction Clinical Trial Fully Enrolled 27 Feb 2020 8:08AM $0.048 $0.500 risen by 941.67%
$7 Appendix 2A and Cleansing Notice 19 Feb 2020 2:14PM $0.055 $0.500 risen by 809.09%
$7 Zelira Meets Primary Endpoints for Insomnia Trial 19 Feb 2020 9:53AM $0.058 $0.500 risen by 762.07%
$7 Trading Halt 17 Feb 2020 9:36AM $0.058 $0.500 risen by 762.07%
$7 Proposed issue of Securities - ZLD 17 Feb 2020 8:22AM $0.058 $0.500 risen by 762.07%
$7 Capital Raising Update 17 Feb 2020 8:21AM $0.058 $0.500 risen by 762.07%
$7 Expiry of unlisted options 7 Feb 2020 6:28PM $0.054 $0.500 risen by 825.93%
$7 Cleansing Notice 6 Feb 2020 7:06PM $0.055 $0.500 risen by 809.09%
$7 Appendix 2A 6 Feb 2020 7:04PM $0.055 $0.500 risen by 809.09%
$7 Proposed issue of Securities - ZLD 5 Feb 2020 9:40AM $0.065 $0.500 risen by 669.23%
$7 Zelira Successfully Completes Capital Raising of $4.6M 5 Feb 2020 9:40AM $0.065 $0.500 risen by 669.23%
$7 Trading Halt 3 Feb 2020 9:45AM $0.065 $0.500 risen by 669.23%
$7 Appendix 4C - quarterly 31 Jan 2020 7:32PM $0.065 $0.500 risen by 669.23%
$7 December 2019 Quarterly Report 31 Jan 2020 7:31PM $0.065 $0.500 risen by 669.23%
$7 Zelira to Collaborate with the Parkinsons Foundation 28 Jan 2020 8:27AM $0.067 $0.500 risen by 646.27%
$7 Ceasing to be a substantial holder 17 Jan 2020 4:06PM $0.057 $0.500 risen by 777.19%
$7 Change in substantial holding 10 Jan 2020 5:51PM $0.060 $0.500 risen by 733.33%
$7 Change of Director's Interest Notice x 3 2 Jan 2020 5:48PM $0.056 $0.500 risen by 792.86%
$7 Appendix 3B and Cleansing Notice 2 Jan 2020 5:47PM $0.056 $0.500 risen by 792.86%
$7 Notification of Expiry of Unlisted Options 2 Jan 2020 5:03PM $0.056 $0.500 risen by 792.86%
$7 Change of Director's Interest Notice x 3 23 Dec 2019 7:32PM $0.055 $0.500 risen by 809.09%
$7 Appendix 3B 23 Dec 2019 3:19PM $0.055 $0.500 risen by 809.09%
$7 Last patient completes dosing in insomnia clinical trial 17 Dec 2019 12:38PM $0.056 $0.500 risen by 792.86%
$7 Official name change to Zelira Therapeutics 4 Dec 2019 5:43PM $0.065 $0.500 risen by 669.23%

326 - 350 of 546 results

Page 14 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.